DANTROLENE SODIUM
Generic: DANTROLENE SODIUM
Amneal Pharmaceuticals of New York LLCManufacturer
ORALRoute
DANTROLENE SODIUMActive Substance
2005-03-01Original Approval
DANTROLENE SODIUM is FDA application ANDA076856, sponsored by IMPAX LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NEUROLEPTIC MALIGNANT SYNDROME
44 reports
2
RESPIRATORY FAILURE
35 reports
3
DRUG INEFFECTIVE
30 reports
4
MUSCULAR WEAKNESS
29 reports
5
ASTHENIA
28 reports
6
PYREXIA
28 reports
7
CONVULSION
26 reports
8
DIARRHOEA
25 reports
9
VOMITING
22 reports
10
OFF LABEL USE
20 reports